Page 134 - 《中国药科大学学报》2025年第5期

666 学报 Journal of China Pharmaceutical University 2025, 56(5): 661 − 666 第 56 卷

plastic agents derived from natural products[J]. Drugs, 2015, 济学), 2022, 17(11): 33-37.
75(17): 1993-2016. [15] Rong HG, Li Q, Dong Y, et al. Analysis of pediatric drug poli-
[7] Li Y, Wen QH, Huo SJ, et al. Analysis on the current situation, cies in China on the basis of policy tools[J]. J China Pharm(中
causes and countermeasures of the supply shortage of pediatric 国药房), 2022, 33(14): 1665-1670.
drug in China[J]. Chin J Drug Eval(中国药物评价), 2023, [16] Wei YN, Shi L, Zhang M, et al. Investigation on current avail-
40(2): 126-129. ability of pediatric drugs in China based on national drug cod-
[8] Chen JX, Huang J, Huang LX, et al. Research of common prob- ing database[J]. Chin J Mod Appl Pharm(中国现代应用药学),
2024, 41(8): 1119-1126.
lems and countermeasures of clinical medication in children[J].
[17] Sun JT, Zhang ZQ, He SW, et al. Progress on novel pediatric
Chin J Clin Rational Drug Use(临床合理用药), 2023, 16(15):
oral solid dosage forms[J]. J China Pharm Univ(中国药科大学
179-181.
学报), 2019, 50(6): 631-640.
[9] Li FS, Yu Q. International development and domestic situation
[18] Ruan WY, Huo JP, Yu B, et al. A multicenter survey of real-
of pediatric medication development and clinical trials[J]. Chin
word data on the accessibility of specific medicines for children
New Drugs J(中国新药杂志), 2020, 29(17): 1933-1938.
in China[J]. Chin New Drugs J(中国新药杂志), 2024, 33(9):
[10] Liu Y, Ji X, Ni MM, et al. Analysis of reasons for subject
849-855.
screening failures and dropouts in pediatric drug clinical
[19] Meng Y, Zhang ZQ, He SW, et al. Advances in research on pe-
trials[J]. Chin Pharm(中国药业), 2024, 33(24): 39-42.
diatric oral liquid dosage forms[J]. J China Pharm Univ(中国药
[11] Yuan J, Zhao QZ, Liu JY, et al. Ethical review of subject pro-
科大学学报), 2021, 52(1): 113-121.
tection in children’s clinical trials[J]. Chin Med Ethics(中国医
[20] Yan JZ, Shao R. "Portrait" of the current status of children’s
学伦理学), 2019, 32(10): 1253-1256.
medicine supply guarantee policy[J]. Chin Health(中国卫生),
[12] Zhang JZ, Ke Y, Shen JL. Recent progress in research and de-
2022(6): 80-83.
velopment of antiepileptics and their situation on market[J].
[21] Teng HL. Children are not simply “miniature” adults: avoiding
Shanghai Med Pharm J(上海医药), 2015, 36(9): 13-15. medication errors[J]. Jiangsu J Health Care(江苏卫生保健),
[13] Zong YG. Analysis and suggestions on the development trend 2022(3): 28-29.
of drug innovation in China[J]. J China Pharm Univ(中国药科 [22] Li YY, Chen C, Wang HX, et al. Problems and innovative de-
大学学报), 2023, 54(3): 380-388. velopment strategies of children’s pharmaceutical
[14] Jiang FL, Liu YJ. Policy research on children’s medicine sup- preparations[J]. Chin J Mod Appl Pharm(中国现代应用药学),
ply guarantee in China[J]. Chin J Pharm Econom(中国药物经 2022, 39(12): 1597-1603.